TD Asset Management
SNDX icon

TD Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

TD Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,760
Closed -$732K – 1424
2024
Q1 		$732K Hold
30,760
– – ﹤0.01% 1236
2023
Q4 		$665K Buy
+30,760
New +$473K ﹤0.01% 1260
2021
Q4 		– Sell
-28,671
Closed -$548K – 1540
2021
Q3 		$548K Hold
28,671
– – ﹤0.01% 1372
2021
Q2 		$418K Hold
28,671
– – ﹤0.01% 1410
2021
Q1 		$641K Buy
28,671
+18,571
+184% +$420K ﹤0.01% 1354
2020
Q4 		$225K Buy
+10,100
New +$209K ﹤0.01% 1416

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return